Sensyne explores dual listing in the US

By
Maria Davies
-
Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health has announced plans to explore a dual listing on NASDAQ. The company, which was founded by former science minister and…

You must be a HM Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR